Unichem Laboratories
Unichem Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Unichem Laboratories
Start SIPUnichem Laboratories Investment Rating
-
Master Rating:
-
Unichem Laboratories has an operating revenue of Rs. 1,319.69 Cr. on a trailing 12-month basis. An annual revenue growth of 2% is not great, Pre-tax margin of 2% needs improvement, ROE of 1% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 1 which is a POOR score indicating inconsistency in earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|
| Oper Rev Qtr Cr | 266 | 245 | 277 |
| Operating Expenses Qtr Cr | 297 | 256 | 264 |
| Operating Profit Qtr Cr | -31 | -11 | 12 |
| Depreciation Qtr Cr | 26 | 23 | 21 |
| Interest Qtr Cr | 3 | 2 | 1 |
| Tax Qtr Cr | 21 | 0 | -18 |
| Net Profit Qtr Cr | -75 | -23 | 17 |
Unichem Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 6
- Bearish Moving Average
- ___
- 10
- 20 Day
- 309.73
- 50 Day
- 322.26
- 100 Day
- 330.87
- 200 Day
- 320.95
- 20 Day
- 303.43
- 50 Day
- 320.55
- 100 Day
- 359.03
- 200 Day
- 315.1
Unichem Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 336.67 |
| Second Resistance | 350.04 |
| Third Resistance | 358.37 |
| RSI | 50.87 |
| MFI | 72.14 |
| MACD Single Line | -4.42 |
| MACD | 1.28 |
| Support | |
|---|---|
| First Resistance | 314.97 |
| Second Resistance | 306.64 |
| Third Resistance | 293.27 |
Unichem Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 111,689 | 6,051,310 | 54.18 |
| Week | 380,794 | 12,688,063 | 33.32 |
| 1 Month | 150,548 | 5,884,927 | 39.09 |
| 6 Month | 217,547 | 10,085,482 | 46.36 |
Unichem Laboratories Result Highlights
Unichem Laboratories Synopsis
NSE-Medical-Diversified
Unichem Labs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 942.93 Cr. and Equity Capital is Rs. 14.08 Cr. for the Year ended 31/03/2022. Unichem Laboratories Ltd. is a Public Limited Listed company incorporated on 22/08/1962 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1962PLC012451 and registration number is 012451.| Market Cap | 2,209 |
| Sales | 1,036 |
| Shares in Float | 3.45 |
| No of funds | 45 |
| Yield | 1.27 |
| Book Value | 0.83 |
| U/D Vol ratio | 0.7 |
| LTDebt / Equity | 3 |
| Alpha | 0.14 |
| Beta | 1.22 |
Unichem Laboratories
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 50.93% | 50.93% | 50.93% | |
| Mutual Funds | 6.78% | 7.29% | 8.08% | |
| Insurance Companies | 0.23% | 0.23% | 0.27% | |
| Foreign Portfolio Investors | 1.56% | 1.71% | 1.5% | |
| Financial Institutions/ Banks | 0.04% | 0.03% | 0.03% | |
| Individual Investors | 30.99% | 30.17% | 29.96% | |
| Others | 9.47% | 9.64% | 9.23% |
Unichem Laboratories Management
| Name | Designation |
|---|---|
| Dr. Prakash A Mody | Chairman & Managing Director |
| Mr. Prafull Anubhai | Independent Director |
| Dr.(Mrs.) B Kinnera Murthy | Independent Director |
| Mr. Prafull Sheth | Independent Director |
| Mr. Anand Mahajan | Independent Director |
| Mr. Dilip Kunkolienkar | Director - Technical |
Unichem Laboratories Forecast
Price Estimates
Unichem Laboratories Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-02-06 | Quarterly Results | |
| 2022-11-11 | Quarterly Results | |
| 2022-08-09 | Quarterly Results | |
| 2022-05-27 | Audited Results & Final Dividend | |
| 2022-01-29 | Quarterly Results |
Unichem Laboratories FAQs
What is Share Price of Unichem Laboratories ?
Unichem Laboratories share price is ₹312 As on 05 February, 2023 | 18:42
What is the Market Cap of Unichem Laboratories ?
The Market Cap of Unichem Laboratories is ₹2202.3 Cr As on 05 February, 2023 | 18:42
What is the P/E ratio of Unichem Laboratories ?
The P/E ratio of Unichem Laboratories is -60.1 As on 05 February, 2023 | 18:42
What is the PB ratio of Unichem Laboratories ?
The PB ratio of Unichem Laboratories is 0.8 As on 05 February, 2023 | 18:42